Steven R. Tannenbaum, PhD



(617) 253-3729
Underwood-Prescott Professor, Emeritus


Biological Mass Spectrometry
Nitric Oxide: Chemistry and Pathophysiology
Tissue Engineering for Drug Development and Chemical Toxicity
Quantitative Ultramicro Measurements for Drug and Carcinogen Metabolism


Member, Center for Environmental Health Sciences


Originally from New York, Professor Tannenbaum began his scientific education at MIT earning a Bachelor of Science in Food Technology. Subsequently, Tannenbaum earned a PhD in Food Science and Technology with a Minor in Chemistry also from MIT. He then joined the MIT faculty in the Department of Nutrition and Food Science which evolved into the Department of Biological Engineering.


For many years, the Tannenbaum lab has been interested in the formation, distribution, and metabolism of nitrate, nitrite, and N-nitroso compounds. This work led to their discovery of the endogenous synthesis of nitrogen oxides and eventually the discovery of nitric oxide as a biological molecule. At present the laboratory is conducting research on the pathophysiological consequences of nitric oxide and its oxidation products. This encompasses cell-mediated nitrosation, free-radical reactions, and oxidation. Of particular interest is the nature of chemical damage to DNA and its genotoxic consequences. From a health point of view this is important for the inflammatory state and for various infections and diseases that increase the risk of cancer. The Tannenbaum group is also interested in the inhibition of these reactions by antioxidants and other substances that offer protection from oxidative stress.

Another great interest of the Tannenbaum lab is tissue engineering for drug development and chemical toxicity. Cells placed in culture generally lose at least some key differentiated physiological functions that they normally exhibit as part of organized tissues in the body. Thus, while cultured cells may be adequate for some applications in drug metabolism and detection of toxins, they are certain to fail for others. The Tannenbaum Lab has developed an in vitro organized tissue-based sensor for detection of unknown toxins and rapid screening of drug metabolism. The technology combines a unique chip-based micro tissue arrangement with mass spectrometric and optical sensors to detect changes in tissue behavior and measure primary and secondary biochemical transformations of drugs and toxins.

The Tannenbaum Lab is also developing new approaches to measure the fate of drugs and chemicals in the classical paradigm for drug metabolism: Absorption, Distribution, Metabolism, Excretion (ADME). The methods include variations in biological Mass Spectrometry and Laser-Induced Fluorescence Spectroscopy. The Tannenbaum laboratory has previously conducted extensive research on the chemistry and structural analysis of biological polymers, including proteins, nucleic acids, and polysaccharides. State-of-the-art mass spectrometry instrumentation has enabled them to make quantitative measurements at the sub-femtomole level. An important new, unique tool is an Accelerator Mass Spectrometer for C14 and tritium that will be directly coupled to gas and liquid chromatography. These tools will enable "Nanotracing" of molecules in humans at heretofore unexplored levels.

Research Areas: 

Selected Publications:

Lu, Kun, Ridwan Mahbub, Peter Hans Cable, Hongyu Ru, Nicola M. A. Parry, Wanda M. Bodnar, John S. Wishnok, Miroslav Styblo, James A. Swenberg, James G. Fox et al. "Gut microbiome phenotypes driven by host genetics affect arsenic metabolism." Chem Res Toxicol 27, no. 2 (2014): 172-4.
Kumar, Yadunanda, Cui Liang, Gino V. Limmon, Li Liang, Bevin P. Engelward, Eng Eong Ooi, Jianzhu Chen, and Steven R. Tannenbaum. "Molecular analysis of serum and bronchoalveolar lavage in a mouse model of influenza reveals markers of disease severity that can be clinically useful in humans." PLoS One 9, no. 2 (2014): e86912.
Henderson, Paul T., James C. Delaney, James G. Muller, William L. Neeley, Steven R. Tannenbaum, Cynthia J. Burrows, and John M. Essigmann. "The hydantoin lesions formed from oxidation of 7,8-dihydro-8-oxoguanine are potent sources of replication errors in vivo." Biochemistry 42, no. 31 (2003): 9257-62.
Chionh, YH, Babu IR, Hia F, Lin W, Dziergowska A, Malkiewicz A, Begley TJ, Alonso S, and Dedon PC. "tRNA-mediated codon-biased translation in mycobacterial hypoxic persistence." Nat Commun 7 (2016).